301. Deputy Joanna Byrne asked the Minister for Health the number of people awaiting orthopaedic outpatient appointments and orthopaedic procedures via Our Lady of Lourdes Hospital, Drogheda for each of the years 2023 to 2025 and to-date in 2026; and the waiting times by urgency category where available. [10591/26]
Parliamentary questions
Questions
TDs ask ministers questions to get answers on the record, most of them in writing. Here is every one asked in the 34th Dáil, by the department it went to and the subject heading it was filed under. How questions work
Browse the questions
395 questions match, newest first.
302. Deputy Joanna Byrne asked the Minister for Health the number of people awaiting ENT (ear, nose and throat) outpatient appointments via Our Lady of Lourdes Hospital, Drogheda for each of the years 2023 to 2025 and to-date in 2026; and the median and longest waits. [10592/26]
303. Deputy Joanna Byrne asked the Minister for Health the number of people awaiting cardiology outpatient appointments and diagnostics in Our Lady of Lourdes Hospital, Drogheda catchment for each of the years 2023 to 2025 and to-date in 2026; and the waiting times involved. [10593/26]
304. Deputy Joanna Byrne asked the Minister for Health the number of persons in County Louth awaiting home support for each of the years 2023 to 2025 and to-date in 2026 including numbers approved but not yet commenced; hours approved vs delivered; and average waiting times. [10594/26]
305. Deputy Joanna Byrne asked the Minister for Health the number of applications from County Louth awaiting decision/placement under the nursing homes support scheme for each of the years 2023 to 2025 and to-date in 2026; and the average time from application to funding decision. [10595/26]
306. Deputy Joanna Byrne asked the Minister for Health the number of children in County Louth awaiting HSE public dental services including special needs dentistry for each of the years 2023 to 2025 and to-date in 2026; and to provide waiting times and staffing levels. [10596/26]
307. Deputy Joe Neville asked the Minister for Health if her Department will provide the current timelines for orthodontist wait lists in the HSE for primary school children in Ireland; and if she will make a statement on the matter. [10607/26]
308. Deputy Joe Neville asked the Minister for Health if her Department will provide the current timelines for orthodontist wait lists in the HSE for primary school children in Kildare; and if she will make a statement on the matter. [10608/26]
309. Deputy Mark Wall asked the Minister for Health the steps being taken to ensure urgent access to welireg (belzutifan) for a young adult with von Hippel-Lindau disease in County Kildare (details supplied) where clinicians advise that delay risks irreversible loss of neurological and functional ability; and if she will make a statement on the matter. [10622/26]
310. Deputy Peadar Tóibín asked the Minister for Health if there is provision of funds to provide for future medical malpractice lawsuits that may be taken against the Government as a result of children having undergone irreversible gender transition surgery. [10623/26]
311. Deputy Seán Ó Fearghaíl asked the Minister for Health if she will address the serious issues raised in correspondence relating to the shingles vaccination (details supplied); and if she will make a statement on the matter. [10632/26]
312. Deputy Niall Collins asked the Minister for Health the office or authority which withdrew the 2017 HSE Position Paper Wind Turbines and Public Health; if, the Office of the Chief Medical Officer and the National Director of Public Health were notified of this withdrawal; if so, the dates of same; if and when the Department of Housing; Local Government and Heritage was similarly notified; and if she will make a s…
313. Deputy Niamh Smyth asked the Minister for Health if she will expedite an appointment for a person (details supplied) as a matter of urgency; and if she will make a statement on the matter. [10646/26]
314. Deputy Niamh Smyth asked the Minister for Health to expedite a procedure for a person (details supplied); and if she will make a statement on the matter. [10652/26]
315. Deputy Ken O'Flynn asked the Minister for Health whether the Health Service Executive has completed, or is in the process of completing, any National Centre for Pharmacoeconomics Rapid Review, Health Technology Assessment, or other formal evaluation for tirzepatide (mounjaro) and semaglutide (wegovy) for obesity or weight management; the date on which each assessment commenced; the current stage reached in each …
316. Deputy Ken O'Flynn asked the Minister for Health whether the Health Service Executive or her Department has prepared, commissioned, received, or reviewed any cost-effectiveness analysis, budget impact analysis, or economic model relating to the use of GLP-1 receptor agonist medicines for obesity or weight management, including semaglutide and tirzepatide; whether any such analysis includes modelling of downstrea…
317. Deputy Ken O'Flynn asked the Minister for Health to outline the policy or decision framework used by the Health Service Executive when considering prevention-based outcomes, including reductions in the future incidence of type 2 diabetes and cardiovascular disease, in medicines reimbursement decisions under the Health (Pricing and Supply of Medical Goods) Act 2013; and whether the Department has issued, or inten…
318. Deputy Ken O'Flynn asked the Minister for Health whether her Department has undertaken or commissioned any assessment of the equity implications of current access arrangements for GLP-1 receptor agonist medicines for obesity or weight management, including the extent to which access is determined by capacity to pay out of pocket rather than clinical need; and whether the forthcoming national obesity strategy wil…
319. Deputy Ken O'Flynn asked the Minister for Health to provide the eligibility criteria, prescribing settings, and clinical governance requirements applying to the managed access system under which liraglutide (Saxenda) is reimbursed under the General Medical Services and Drugs Payment Schemes; and to provide the number of patients approved under this pathway in each of the years 2024 and 2025, and to date in 2026.…
320. Deputy Ken O'Flynn asked the Minister for Health the current policy position of her Department on whether GLP-1 receptor agonist medicines for obesity or weight management should be eligible for reimbursement under the Drugs Payment Scheme, subject to health technology assessment and clinical governance; whether any policy review is under way in the context of the development of the new national obesity strategy…
321. Deputy Ken O'Flynn asked the Minister for Health whether the national obesity strategy currently in development will explicitly address the role of pharmacological treatment for obesity, including eligibility, reimbursement pathways, and equity of access; and whether she will outline how medicines policy is being aligned with the objectives of that strategy. [10660/26]
322. Deputy Pat Buckley asked the Minister for Health to establish a national screening programme for prostate cancer, given the significance of early detection in improving health outcome, patient prognosis and quality of life. [10665/26]
323. Deputy Pat Buckley asked the Minister for Health to review and consider the provision of full medical cards for persons living with spinal injuries; and if she will make a statement on the matter. [10666/26]
324. Deputy Ken O'Flynn asked the Minister for Health whether her Department recognises that, for some people with disabilities and people receiving home-care supports, pharmacist-prepared monitored dosage systems, including blister packs, are clinically required to ensure safe medication administration and compliance; whether any national clinical guidance, policy circular, or Department-approved criteria exist to d…
325. Deputy Ken O'Flynn asked the Minister for Health whether her Department has undertaken, or commissioned, any patient safety or risk assessment regarding the withdrawal or non-funding of pharmacist-prepared blister packs for people with disabilities or cognitive impairment who rely on such supports in a home-care setting; the findings of any such assessment; and if none has been undertaken, when such an assessmen…